Most Read Articles
Rachel Soon, 16 Nov 2019

The third Pharmaceutical Industry Pharmacists Insight (PIPI 3.0) symposium will highlight areas of the pharmaceutical industry often overlooked by those entering the pharmacy profession.

Jairia Dela Cruz, 23 Apr 2019
Rupatadine at either 10 or 20 mg delivers superior improvements in nasal and ocular symptoms of seasonal allergic rhinitis compared with placebo, with both doses well tolerated by adult and adolescent patients, according to the results of a phase III trial.
02 Dec 2019
Podcast: Associate Prof Pilar Garrido says osimertinib may be the best option in the first-line treatment of advanced NSCLC based on FLAURA OS results.
Pearl Toh, 20 Dec 2019
Faecal microbiota transplantation (FMT) is effective in reducing symptoms of irritable bowel syndrome (IBS), but having a “super-donor” is key, a study presented at UEG* Week has shown — highlighting the importance of donor selection for the success of FMT as a treatment for IBS.

More women discontinue antihypertensive treatment than men

14 Jan 2020

More women than men cease from taking their antihypertensive medication, as shown by the results of a recent study conducted in a real-life setting.

The investigators sought to compare persistence with antihypertensive drug therapy between men and women in a large cohort of patients. They identified a total of 60,526 residents of the Italian Lombardy Region, who were aged 40–80 years and newly treated with antihypertensive drugs during 2010, and followed them for 1 year after the first prescription.

Treatment discontinuation was defined as lack of prescription renewal for at least 90 days. The risk ratio of treatment discontinuation in relation to sex was estimated by fitting log-binomial regression models. Analyses were stratified according to age, comorbidity status and the initial antihypertensive treatment strategy.

Of the participants, 37 percent discontinued antihypertensive treatment during follow-up. The risk of treatment discontinuation was 10-percent (95 percent confidence interval, 8–12) lower in men than in women. In addition, men showed better adherence to antihypertensive treatment than women, and this was true in both younger (40–64 years) and older patients (65–80 years), in patients starting treatment with any major antihypertensive drug, and in patients with a low comorbidity status.

However, no evidence was found on whether men and women had a different risk of treatment discontinuation when their comorbidity status was worse or initial antihypertensive treatment was based on drug combinations.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 16 Nov 2019

The third Pharmaceutical Industry Pharmacists Insight (PIPI 3.0) symposium will highlight areas of the pharmaceutical industry often overlooked by those entering the pharmacy profession.

Jairia Dela Cruz, 23 Apr 2019
Rupatadine at either 10 or 20 mg delivers superior improvements in nasal and ocular symptoms of seasonal allergic rhinitis compared with placebo, with both doses well tolerated by adult and adolescent patients, according to the results of a phase III trial.
02 Dec 2019
Podcast: Associate Prof Pilar Garrido says osimertinib may be the best option in the first-line treatment of advanced NSCLC based on FLAURA OS results.
Pearl Toh, 20 Dec 2019
Faecal microbiota transplantation (FMT) is effective in reducing symptoms of irritable bowel syndrome (IBS), but having a “super-donor” is key, a study presented at UEG* Week has shown — highlighting the importance of donor selection for the success of FMT as a treatment for IBS.